';

QuantuMDx is dedicated to improving and democratising global health by providing transformative diagnostic tools to overburdened healthcare systems.

QuantuMDx Group is a multinational life sciences tools and diagnostics developer headquartered in the United Kingdom, with subsidiary operations in the United States and Singapore.

The company is dedicated to democratising global healthcare, thereby enabling communities worldwide to thrive. QuantuMDx is transforming molecular diagnostics with the development of leapfrog technologies for use under the tree and in clinics, pharmacies, hospitals and labs.

The company’s product range innovates each aspect of the DNA testing process, from extraction to amplification to detection.

QMDx_Q-POC_TESTICOM

QuantuMDx has received grants from the UK and EU governments, and partnered with FIND in 2014.
QuantuMDx was founded in March 2008
QuantuMDx has over 60 staff in 
3 locations
QuantuMDx has received 10 awards
Investors
The company has raised funds through both grants and private investment.

QMDx_IP_Logos_144

Strong IP
QuantuMDx has exclusive licenses, a strong owned IP portfolio and utilises off-patent technologies. The patent portfolio comprises IP surrounding each of the component technologies and products in our range.
13
Patent Families
26
Granted Patents
7
Provisional Patents Pending
applications for its technologies

Subscribe to our e-newsletter and keep up to date with QuantuMDx

THE FUTURE OF DIAGNOSTICS

Contact

Contact

Contact